Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Israeli lawmakers pass bill reviving death penalty for terrorists - 2Instructions to Pick the Ideal Pre-assembled Home for Your Necessities
- 3Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
- 4Gulf aluminum output tumbles on Iran war
- 5Yasser Abu Shabab's killing raises questions about Israel's militia strategy in Gaza
- Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs
- Figure out How to Assess the Unwavering quality of SUVs for Seniors
- Best Amusement Park in Europe: Where Do You Very much want to Visit?
- 6 Web-based Course Stages for Successful Learning and Educating
- The Main 20 Gaming Control center Ever
- A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
- Instructions to Choose the Best Material Organization for a Fruitful Rooftop Substitution
- People who talk with their hands seem more clear and persuasive – new research
- New India programme supports tribal families hosting tourists
